Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Community-Acquired Pneumonia. Reply.
File TM Jr, Ramirez JA. File TM Jr, et al. N Engl J Med. 2023 Oct 26;389(17):1633-1634. doi: 10.1056/NEJMc2310748. N Engl J Med. 2023. PMID: 37888934 No abstract available.
Community-Acquired Pneumonia.
File TM Jr, Ramirez JA. File TM Jr, et al. N Engl J Med. 2023 Aug 17;389(7):632-641. doi: 10.1056/NEJMcp2303286. N Engl J Med. 2023. PMID: 37585629 Review. No abstract available.
A plain language summary of how lefamulin alone can be used to treat pneumonia caught outside of the hospital due to common bacterial causes, including drug-resistant bacteria.
Paukner S, Moran GJ, Sandrock C, File TM Jr, Vidal JE, Waites KB, Gelone SP, Yu K. Paukner S, et al. Among authors: file tm jr. Future Microbiol. 2022 Apr;17(6):397-410. doi: 10.2217/fmb-2021-0276. Epub 2022 Mar 14. Future Microbiol. 2022. PMID: 35285291 Free PMC article. Review.
Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin.
Paukner S, Goldberg L, Alexander E, Das AF, Heinrich S, Patel P, Moran GJ, Sandrock C, File TM Jr, Vidal JE, Waites KB, Gelone SP, Schranz J. Paukner S, et al. Among authors: file tm jr. J Glob Antimicrob Resist. 2022 Jun;29:434-443. doi: 10.1016/j.jgar.2021.10.021. Epub 2021 Nov 14. J Glob Antimicrob Resist. 2022. PMID: 34788694 Free article. Clinical Trial.
Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment.
Cornely OA, File TM Jr, Garrity-Ryan L, Chitra S, Noble R, McGovern PC. Cornely OA, et al. Among authors: file tm jr. Int J Antimicrob Agents. 2021 Feb;57(2):106263. doi: 10.1016/j.ijantimicag.2020.106263. Epub 2020 Dec 14. Int J Antimicrob Agents. 2021. PMID: 33326848 Free article.
Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe.
Huang DB, Magnet S, De Angelis S, Holland TL, File TM Jr, Dryden M, Corey GR, Torres A, Wilcox MH. Huang DB, et al. Among authors: file tm jr. Diagn Microbiol Infect Dis. 2019 Feb;93(2):154-158. doi: 10.1016/j.diagmicrobio.2018.09.002. Epub 2018 Sep 10. Diagn Microbiol Infect Dis. 2019. PMID: 30266399 Free article.
196 results